 |
CHICAGO, July 29, 2025 /PRNewswire/ -- Fapon, a global leading life sciences company, will debut its Shine mT8000 Fully Automated Clinical Chemistry and Immunoassay System at the ADLM 2025 Annual Scientific Meeting. This launch marks a significant milestone in Fapon's commitment to building an open, intelligent, and high-efficiency diagnostic ecosystem that helps clinical laboratories to enhance efficiency for clinical chemistry and immunoassays.
The Shine mT8000 system packs powerful performance into a footprint just 5 square meters, combining biochemistry and immunoassay capabilities in one compact, all-in-one platform. With an exceptional throughput density of 735 tests/hour/, the mT8000 is engineered for modern laboratories to maximize output while minimizing space.
Key Features of the Shine mT8000 Include:
- Ultra-fast Testing Dual Engine: The Shine Mt8000 delivers exceptional throughput with 2,400 tests/hour in biochemistry, 600 tests/hour in electrolytes and 900 tests/hour in immunoassays. It supports full-process testing directly from a whole blood samples. AI- powered centralized software streamlines workflows, shortens turnaround times, and prioritizes emergency and STAT samples with increased precision.
- Modular Design: Designed for flexibility, the mT8000 supports biochemistry-only, immunoassay- only, or controlled workflows. Optional modules for sample pre-processing and customizable detection speeds permit labs to scale and adapt as needed.
- Smart Automation and Safety: Built-in AI monitoring ensures accurate sample tracking and error detection. Instrument features such as auto-centrifugation, automated maintenance, and full-blood pre-treatment to minimize manual handling and improved biosafety.
- Open and Compatible Ecosystem: The platform supports four major chemiluminescence systems AP, AE, HRP, and ABEI- and shared reagents across the Shine series, ensuring seamless integration and maximum adaptability.
With the launch of the Shines mT8000, Fapon continues its mission to deliver open, intelligent, and comprehensive diagnostic solutions. The Shine series now includes a spectrum of CLIA analyzers covering low to ultra-high throughput needs, with over 8,000 units deployed globally
Fapon's ever expanding portfolio of assays now include over 70 self-developed CLIA reagent assays on track to expand to over 200 alongside compact immunofluorescence platforms for a wide range of clinical testing scenarios. Backed by vertical integration from raw materials to instruments, Fapon ensures reliable performance and rapid deployment.
The CLIA One-Stop Solution provides end-to-end support, including open platform instrument platforms, fast-track reagent development and high-quality raw material supplies - empowering laboratories and the IVD industry to respond faster, smarter and with confidence.
Join Us at ADLM 2025
Fapon Biotech warmly invites all attendees to visit our booth 3816 at ADLM 2025 to witness the official release of the Shine mT8000.
About Fapon
Fapon is a global leading life sciences company dedicated to providing integrated solutions and services for diagnostics, biopharma and biotherapy. Integrating a one-stop solution on raw materials, reagents and innovative open instrument platforms, the Company has grown into a leading supplier in in-vitro diagnostics. Fapon boasts advanced innovations in therapeutics technologies and AI algorithm platforms with data insights that contribute to a better and healthier world. Supported by its strong global R&D, manufacturing, sales and service network, Fapon's products have established presence in over 70 countries and regions, serving more than 2,500 business partners worldwide.
Follow us on LinkedIn (Fapon) or visit our website https://us.faponbiotech.com
CHICAGO, July 29, 2025 /PRNewswire/ -- Fapon, a global leading life sciences company, will debut its Shine mT8000 Fully Automated Clinical Chemistry and Immunoassay System at the ADLM 2025 Annual Scientific Meeting. This launch marks a significant milestone in Fapon's commitment to building an open, intelligent, and high-efficiency diagnostic ecosystem that helps clinical laboratories to enhance efficiency for clinical chemistry and immunoassays.
The Shine mT8000 system packs powerful performance into a footprint just 5 square meters, combining biochemistry and immunoassay capabilities in one compact, all-in-one platform. With an exceptional throughput density of 735 tests/hour/, the mT8000 is engineered for modern laboratories to maximize output while minimizing space.
Key Features of the Shine mT8000 Include:
- Ultra-fast Testing Dual Engine: The Shine Mt8000 delivers exceptional throughput with 2,400 tests/hour in biochemistry, 600 tests/hour in electrolytes and 900 tests/hour in immunoassays. It supports full-process testing directly from a whole blood samples. AI- powered centralized software streamlines workflows, shortens turnaround times, and prioritizes emergency and STAT samples with increased precision.
- Modular Design: Designed for flexibility, the mT8000 supports biochemistry-only, immunoassay- only, or controlled workflows. Optional modules for sample pre-processing and customizable detection speeds permit labs to scale and adapt as needed.
- Smart Automation and Safety: Built-in AI monitoring ensures accurate sample tracking and error detection. Instrument features such as auto-centrifugation, automated maintenance, and full-blood pre-treatment to minimize manual handling and improved biosafety.
- Open and Compatible Ecosystem: The platform supports four major chemiluminescence systems AP, AE, HRP, and ABEI- and shared reagents across the Shine series, ensuring seamless integration and maximum adaptability.
With the launch of the Shines mT8000, Fapon continues its mission to deliver open, intelligent, and comprehensive diagnostic solutions. The Shine series now includes a spectrum of CLIA analyzers covering low to ultra-high throughput needs, with over 8,000 units deployed globally
Fapon's ever expanding portfolio of assays now include over 70 self-developed CLIA reagent assays on track to expand to over 200 alongside compact immunofluorescence platforms for a wide range of clinical testing scenarios. Backed by vertical integration from raw materials to instruments, Fapon ensures reliable performance and rapid deployment.
The CLIA One-Stop Solution provides end-to-end support, including open platform instrument platforms, fast-track reagent development and high-quality raw material supplies - empowering laboratories and the IVD industry to respond faster, smarter and with confidence.
Join Us at ADLM 2025
Fapon Biotech warmly invites all attendees to visit our booth 3816 at ADLM 2025 to witness the official release of the Shine mT8000.
About Fapon
Fapon is a global leading life sciences company dedicated to providing integrated solutions and services for diagnostics, biopharma and biotherapy. Integrating a one-stop solution on raw materials, reagents and innovative open instrument platforms, the Company has grown into a leading supplier in in-vitro diagnostics. Fapon boasts advanced innovations in therapeutics technologies and AI algorithm platforms with data insights that contribute to a better and healthier world. Supported by its strong global R&D, manufacturing, sales and service network, Fapon's products have established presence in over 70 countries and regions, serving more than 2,500 business partners worldwide.
Follow us on LinkedIn (Fapon) or visit our website https://us.faponbiotech.com
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Fapon to Debut Shine mT8000 Open-Access, High Throughput Clinical Chemistry and Immunoassay Analyzer at ADLM 2025
|
MELBOURNE, Australia, Jan. 17, 2026 /PRNewswire/ -- Panduit, a global leader in electrical and network infrastructure solutions, today announced the promotion of Holly Garcia to Chief Commercial Officer. In this role, Garcia will lead the company's global commercial strategy, focusing on the company's commitment to innovation and delivering a best-in-class experience for customers. Garcia will report directly to Panduit President, Marc Naese.
"Holly has the vision and expertise to position our company for continued growth and success while deepening our customer relationships," said Naese. "Holly's leadership as Chief Commercial Officer will be instrumental in strengthening the customer experience and delivering the value our markets expect."
In her most recent role as Vice President of Panduit's Data Center business unit, Garcia spearheaded global growth and innovation initiatives. She led the development of business strategy and directed new product introductions to strengthen Panduit's position in the rapidly evolving data center market. With more than 25 years of experience in sales, marketing, and business unit leadership, Garcia brings a proven track record of driving commercial success and transformative growth.
"I'm honored to take on the role of Chief Commercial Officer and excited to lead our commercial strategy during this time of growth," explained Garcia. "Our team's commitment to innovation and customer success has positioned us as a trusted partner globally, and I look forward to driving even greater value for our customers and stakeholders."
About Panduit
Panduit is a leading global manufacturer of high-quality electrical and network infrastructure and connectivity solutions. Operating from our headquarters in Tinley Park, Ill., USA, and across 112 worldwide locations, we drive innovation through strategic R&D investments and breakthrough product development while providing seamless global support and service. Since 1955, our commitment to our customers and partners has remained constant. And together, with them, we create exceptional solutions that support their businesses in a way that's good for them and good for the world. Panduit is making the connections that matter. For more information, visit www.panduit.com.
Media Contact:
Dawn Leach
Manager, Global Brand
Panduit Corp.
708-532-1800 x81316
dawn.leach@panduit.com
MELBOURNE, Australia, Jan. 17, 2026 /PRNewswire/ -- Panduit, a global leader in electrical and network infrastructure solutions, today announced the promotion of Holly Garcia to Chief Commercial Officer. In this role, Garcia will lead the company's global commercial strategy, focusing on the company's commitment to innovation and delivering a best-in-class experience for customers. Garcia will report directly to Panduit President, Marc Naese.
"Holly has the vision and expertise to position our company for continued growth and success while deepening our customer relationships," said Naese. "Holly's leadership as Chief Commercial Officer will be instrumental in strengthening the customer experience and delivering the value our markets expect."
In her most recent role as Vice President of Panduit's Data Center business unit, Garcia spearheaded global growth and innovation initiatives. She led the development of business strategy and directed new product introductions to strengthen Panduit's position in the rapidly evolving data center market. With more than 25 years of experience in sales, marketing, and business unit leadership, Garcia brings a proven track record of driving commercial success and transformative growth.
"I'm honored to take on the role of Chief Commercial Officer and excited to lead our commercial strategy during this time of growth," explained Garcia. "Our team's commitment to innovation and customer success has positioned us as a trusted partner globally, and I look forward to driving even greater value for our customers and stakeholders."
About Panduit
Panduit is a leading global manufacturer of high-quality electrical and network infrastructure and connectivity solutions. Operating from our headquarters in Tinley Park, Ill., USA, and across 112 worldwide locations, we drive innovation through strategic R&D investments and breakthrough product development while providing seamless global support and service. Since 1955, our commitment to our customers and partners has remained constant. And together, with them, we create exceptional solutions that support their businesses in a way that's good for them and good for the world. Panduit is making the connections that matter. For more information, visit www.panduit.com.
Media Contact:
Dawn Leach
Manager, Global Brand
Panduit Corp.
708-532-1800 x81316
dawn.leach@panduit.com
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Panduit Strengthens Commitment to Customer Excellence with Appointment of Holly Garcia to Chief Commercial Officer
